Drs. Gerard Anderson, professor, and Joseph Levy, assistant scientist, in the department of health policy and management at the Johns Hopkins Bloomberg School of Public Health have been appointed to Maryland’s first Prescription Drug Affordability Panel. This panel, the first in the U.S., will help set prescription drug costs for Maryland residents, starting with prescription drugs whose prices are more than $30,000 dollars per year or have a price increase of at least $3,000 dollars from one year to the next.
Nationwide, high prescription drug prices are increasingly making medications unaffordable. The Board was created by Maryland’s state legislature in 2019 to set upper payment limits for prescription drugs purchased by state, county, or local governments beginning in 2022. Public hearings across the state will help inform the Board which drugs should be investigated. Other states are looking to establish similar boards and will look to Maryland for guidance.
Dr. Anderson was appointed by Maryland Attorney General Brian Frosh and Dr. Levy was appointed by Maryland Governor Larry Hogan. Each will serve a five-year term that can be renewed.
Dr. Anderson is director of the Center for Hospital Finance and Management at the Bloomberg School. His research focuses on drug and health pricing, and he testifies regularly before Congress, state legislatures, and federal agencies. Dr. Levy is a health economist who studies the cost-effectiveness of medical technologies, primarily in orthopedic trauma, as well as state and federal polices related to drug pricing.Friday Letter Submission, Publish on January 24